Investigational therapy focuses on slowing progression in mild to moderate Alzheimer's
Wednesday, August 20, 2014 - 14:51
in Health & Medicine
Patients with mild to moderate Alzheimer’s disease currently have no treatment options to slow brain cell deterioration. Researchers are studying an investigational drug that proposes to do just that.